Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.41B |
| 2 |
Microchip Technology
MCHP
|
+$691M |
| 3 |
Microsoft
MSFT
|
+$554M |
| 4 |
PepsiCo
PEP
|
+$534M |
| 5 |
Sunoco
SUN
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$649M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$490M |
| 3 |
NS
NuStar Energy L.P.
NS
|
+$431M |
| 4 |
Flutter Entertainment
FLUT
|
+$424M |
| 5 |
UDR
UDR
|
+$392M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.83% |
| 2 | Financials | 11.94% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 10.48% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Karyopharm Therapeutics
KPTI
$159M
| $35.1K | ﹤0.01% |
2,701
+836
| +45% | +$13.8K |
|
3752
AXT Inc
AXTI
$3.07B
| $34.8K | ﹤0.01% |
+10,304
| New | +$36K |
|
3753
Nerdy
NRDY
$107M
| $34.4K | ﹤0.01% |
20,587
| – | – |
|
3754
Werewolf Therapeutics
HOWL
$24.3M
| $34.2K | ﹤0.01% |
+14,028
| New | +$67.4K |
|
|
ADAP
3755
DELISTED
Adaptimmune Therapeutics
ADAP
| $33.9K | ﹤0.01% |
+34,743
| New | +$38.1K |
|
|
VXRT
3756
DELISTED
Vaxart
VXRT
| $32.1K | ﹤0.01% |
+48,171
| New | +$40K |
|
3757
374Water
SCWO
$39.2M
| $31.3K | ﹤0.01% |
2,605
| – | – |
|
|
KYNB
3758
Kyntra Bio
KYNB
$27.5M
| $30.7K | ﹤0.01% |
1,377
-215
| -14% | -$6.64K |
|
3759
Compugen
CGEN
$220M
| $30.4K | ﹤0.01% |
+18,092
| New | +$37.7K |
|
3760
BigBear.ai
BBAI
$1.36B
| $29.6K | ﹤0.01% |
19,590
+5,300
| +37% | +$8.28K |
|
3761
Seres Therapeutics
MCRB
$46.3M
| $28.4K | ﹤0.01% |
1,963
-1,185
| -38% | -$19.8K |
|
3762
CytomX Therapeutics
CTMX
$714M
| $28.2K | ﹤0.01% |
+23,094
| New | +$46K |
|
3763
Ovid Therapeutics
OVID
$442M
| $22.2K | ﹤0.01% |
28,850
-704
| -2% | -$1.96K |
|
3764
System1
SST
$14.5M
| $16.5K | ﹤0.01% |
1,084
-3,590
| -77% | -$60.6K |
|
|
LLAP
3765
DELISTED
Terran Orbital Corporation
LLAP
| $16.4K | ﹤0.01% |
20,015
+397
| +2% | +$426 |
|
3766
Tevogen Bio Holdings
TVGN
$28.4M
| $7.43K | ﹤0.01% |
+205
| New | +$13.4K |
|
|
LYRA
3767
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $6.32K | ﹤0.01% |
456
-10,649
| -96% | -$1.2M |
|
|
PRST
3768
DELISTED
Presto Technologies, Inc. Common Stock
PRST
| $1.56K | ﹤0.01% |
+22,310
| New | +$3.25K |
|
|
LPTV
3769
DELISTED
Loop Media, Inc.
LPTV
| $1.22K | ﹤0.01% |
12,027
-4,021
| -25% | -$991 |
|
3770
Adicet Bio
ACET
$84.7M
| – | – |
-777
| Closed | -$29.2K |
|
3771
Aclaris Therapeutics
ACRS
$743M
| – | – |
-30,498
| Closed | -$37.8K |
|
|
AEF
3772
abrdn Emerging Markets Equity Income Fund
AEF
$348M
| – | – |
-17,391
| Closed | -$87.8K |
|
|
ALLK
3773
DELISTED
Allakos
ALLK
| – | – |
-30,594
| Closed | -$38.5K |
|
3774
AlTi Global
ALTI
$399M
| – | – |
-27,115
| Closed | -$153K |
|
3775
Amylyx Pharmaceuticals
AMLX
$2.31B
| – | – |
-24,349
| Closed | -$69.2K |
|
Similar funds
Invesco's Q2 2024 Portfolio in Review
As of Q2 2024, Invesco held 4,042 positions worth $473B, up 1.6% from $466B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q2 2024 filing shows 191 new, 1,771 increased, 1,786 reduced and 173 closed positions. Its largest new stake was Solventum: 3,404,015 shares worth $180M. The largest sale was NVIDIA, an estimated $649M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2024 buy was Solventum: 3,404,015 shares worth $180M.
- Invesco added most to Apple in Q2 2024, an estimated $1.41B increase.
- Invesco's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $649M.
- Invesco fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $490M.
- Invesco's ten largest holdings make up 18% of its $473B portfolio in Q2 2024.
- Invesco opened 191 new positions and closed 173 in Q2 2024.
- Invesco's portfolio value rose 1.6% quarter-over-quarter to $473B.
Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.